Archive for the ‘Biotechnology’ Category
Jonathan Dinman to Direct the Institute for Bioscience and Biotechnology Research – College of Computer, Mathematical, and Natural Sciences
♫ Sunday, November 3rd, 2024Jonathan Dinman to Direct the Institute for Bioscience and Biotechnology Research College of Computer, Mathematical, and Natural Sciences
PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts – MarketBeat
♫ Sunday, November 3rd, 2024PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts MarketBeat
Read the rest here:
PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts - MarketBeat
COP16, DSI mechanism for benefit sharing from the use of digital sequence information approved – Renewable Matter
♫ Sunday, November 3rd, 2024COP16, DSI mechanism for benefit sharing from the use of digital sequence information approved Renewable Matter
Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets – PR Newswire
♫ Sunday, November 3rd, 2024See the article here:
Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets - PR Newswire
Axonis Therapeutics raises $115 million in Series A financing – The Pharma Letter
♫ Sunday, November 3rd, 2024Axonis Therapeutics raises $115 million in Series A financing The Pharma Letter
Read this article:
Axonis Therapeutics raises $115 million in Series A financing - The Pharma Letter
Regeneron third-quarter 2024 earnings top expectations – The Pharma Letter
♫ Sunday, November 3rd, 2024Regeneron third-quarter 2024 earnings top expectations The Pharma Letter
Here is the original post:
Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter
AbbVie inks up to $1.4 billion deal with EvolveImmune – The Pharma Letter
♫ Sunday, November 3rd, 2024AbbVie inks up to $1.4 billion deal with EvolveImmune The Pharma Letter
See the original post:
AbbVie inks up to $1.4 billion deal with EvolveImmune - The Pharma Letter
The transformative potential of biotechnology and AI in healthcare – The Armchair Trader
♫ Sunday, November 3rd, 2024The transformative potential of biotechnology and AI in healthcare The Armchair Trader
Read more from the original source:
The transformative potential of biotechnology and AI in healthcare - The Armchair Trader
CEO and Chairman of the Executive Board – European Biotechnology News
♫ Sunday, November 3rd, 2024CEO and Chairman of the Executive Board European Biotechnology News
See more here:
CEO and Chairman of the Executive Board - European Biotechnology News
U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 – BioSpace
♫ Sunday, October 6th, 2024Read the original:
U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace
Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company – Yahoo Finance
♫ Sunday, October 6th, 2024Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company Yahoo Finance
Originally posted here:
Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance
Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -…
♫ Sunday, October 6th, 2024See original here:
Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -...
Resolution Therapeutics scores 63.5 million in series B round – The Pharma Letter
♫ Sunday, October 6th, 2024Resolution Therapeutics scores 63.5 million in series B round The Pharma Letter
View original post here:
Resolution Therapeutics scores 63.5 million in series B round - The Pharma Letter
Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist – AOL
♫ Sunday, October 6th, 2024Spyre Therapeutics lures Abivax exec to be its CMO – The Pharma Letter
♫ Sunday, October 6th, 2024Spyre Therapeutics lures Abivax exec to be its CMO The Pharma Letter
Read the original here:
Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter
Sapience Therapeutics Announces Participation at the 4th Annual Needham Private Biotech Company Virtual 1×1 Forum – PR Newswire
♫ Sunday, October 6th, 2024Convergence is AIxBio: AI and the Bioeconomy – OODA Loop
♫ Sunday, October 6th, 2024Convergence is AIxBio: AI and the Bioeconomy OODA Loop
See the rest here:
Convergence is AIxBio: AI and the Bioeconomy - OODA Loop
Congress targets Chinese influence in health tech. It could come with tradeoffs – ABC News
♫ Friday, September 13th, 2024Congress targets Chinese influence in health tech. It could come with tradeoffs ABC News
Read this article:
Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News
Researchers, media engage to educate farmers on biotechnology – University World News
♫ Friday, September 13th, 2024Researchers, media engage to educate farmers on biotechnology University World News
Visit link:
Researchers, media engage to educate farmers on biotechnology - University World News